End-stage kidney disease

This trial tests whether a specially designed 4-week diet can improve mineral balance and reduce cardiovascular risk in people with end-stage kidney disease on dialysis. The diet aims to correct common problems like high phosphate levels and inflammation. Researchers will compare…

This trial tests a comprehensive approach to improve kidney care and increase transplant rates. It combines provider training, digital dashboards, and a mobile health app to educate patients and help them find living donors. The study includes 5,000 adults with advanced chronic k…

This study compares two types of surgery to create dialysis access in older adults (60+) with end-stage kidney disease. One method connects a vein directly to an artery (fistula), the other uses a synthetic tube (graft). The goal is to see which leads to fewer infections and more…

This study tests whether a bedside device called Quantra can help doctors decide when to give blood transfusions during complex heart surgery. The device measures how well a patient's blood clots in real time. Researchers hope this will reduce the number of blood products (like r…

This study looks at whether adding more magnesium to the fluid used during dialysis can help people with kidney failure live longer and have fewer heart-related hospital stays. Many dialysis patients have low magnesium, which can lead to muscle cramps and heart issues. The trial …

This study tests an oral drug called vadadustat (Vafseo) for treating anemia in people with end-stage kidney disease who are on hemodialysis. About 2,200 adults will be randomly assigned to take vadadustat three times a week or continue standard injectable treatments. The goal is…

This study tests whether delivering specially designed meals can improve nutrition in elderly, low-income patients with end-stage kidney disease who are on dialysis. Twenty-five participants will first eat their usual diet for 4 weeks, then receive personalized meals for another …

This early study tests whether the drug belumosudil, given with donor stem cells, can help the body accept a new kidney without needing strong anti-rejection drugs for life. Sixteen adults with end-stage kidney disease will receive a living donor kidney and stem cell transplant, …

This trial tests whether exercise done during dialysis sessions can help people with end-stage kidney disease think more clearly and feel better day-to-day. Participants will be randomly assigned to standard care alone or to one of three exercise programs—aerobic, resistance, or …

This study tests a small, battery-powered headband that delivers a gentle electrical pulse to the scalp to help reduce chronic pain in people with end-stage kidney disease who are on dialysis. About 125 adults will use the device at home and report their pain levels. The goal is …

This study tests whether a 5-week virtual reality program that teaches positive thinking skills can help reduce depression and improve quality of life in people on hemodialysis. Sixty-one adults with end-stage kidney disease and mild-to-moderate depressive symptoms will either re…

This study compares three ways to check for fluid overload (too much fluid in the body) in people doing dialysis at home. Researchers will ask about symptoms, do a physical exam, and use a safe ultrasound of the lungs. The goal is to find which method works best to help prevent h…

This study looks at how the drug eloralintide enters the bloodstream and leaves the body in people with severe kidney disease or kidney failure, compared to healthy volunteers. About 28 participants will receive a single shot under the skin. The study lasts about 14 weeks and doe…

This study tests whether a tele-health navigator program can help more kidney transplant candidates find living donors. About 347 adults with end-stage kidney disease will either get the navigator support or standard care. The goal is to see if remote guidance increases donor scr…

This early study is testing whether the diabetes and heart failure drug empagliflozin (Jardiance) is safe for people on dialysis for kidney failure. The drug is already approved for other uses but has not been studied in dialysis patients. Researchers will give 24 participants ei…

This study tests a program that gives kidney failure patients personalized support to help them find a living donor for a kidney transplant. The goal is to increase the number of living donor transplants in Alberta, Canada. About 66 patients will take part, and researchers will t…

This pilot study tests a support program called MuST AKT for people with kidney failure who need a transplant. The program helps patients talk to family and friends about living kidney donation. Researchers want to see if this support leads to more potential donors starting the e…

This study was designed to observe people with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) to understand how the disease naturally progresses and how well current treatments work. It planned to enroll adults diagnosed with CKD or ESKD and follow their health …